Stock listing
NASDAQ:VRAX Virax Biolabs Group Limited Stock
Home listing (NASDAQ) of Virax Biolabs Group Limited
Follow Virax Biolabs Group Limited into a list and get an email when it puts out news.
Share price · NASDAQ:VRAX
$1.20 USD +0.14 (+13.2%)
Close on Nov 4, 2026
- Day range
- $1.11 – $1.57 USDNov 4, 2026
- Volume
- 7.75M sharesNov 4, 2026
- Market cap
- $1.61M USDAt the close on Nov 4, 2026 · price × 1.34M shares outstanding
- 52-week range
- $1.04 – $21.75 USDLowest and highest trades, Nov 5, 2025 – Nov 4, 2026
- Traded on an average day
- $1.25M USDMedian day 36,750 shares · last 3 months, Aug 4, 2026 – Nov 4, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VRAX · Home | $1.20 USD | +0.14 (+13.2%) | 7,752,243 | $1.16 | $1.57 | $1.11 | $1.06 | Close on Nov 4, 2026 |
Daily closes
Last 3 months, Aug 4, 2026 – Nov 4, 2026 · NASDAQ:VRAX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.20 | +0.14 | +13.2% | $1.16 | $1.57 | $1.11 | 7,752,243 | |
| $1.06 | -0.04 | -3.6% | $1.09 | $1.175 | $1.04 | 33,430 | |
| $1.10 | -0.11 | -9.1% | $1.152 | $1.18 | $1.10 | 24,228 | |
| $1.21 | -0.11 | -8.3% | $1.285 | $1.285 | $1.18 | 23,492 | |
| $1.32 | +0.12 | +10.0% | $1.30 | $1.33 | $1.235 | 57,672 | |
| $1.20 | +0.01 | +0.8% | $1.17 | $1.21 | $1.16 | 10,044 | |
| $1.19 | 0.00 | 0.0% | $1.23 | $1.23 | $1.14 | 11,908 | |
| $1.19 | -0.03 | -2.5% | $1.26 | $1.26 | $1.18 | 10,414 | |
| $1.22 | -0.015 | -1.2% | $1.24 | $1.265 | $1.20 | 33,900 | |
| $1.235 | -0.105 | -7.8% | $1.29 | $1.39 | $1.15 | 38,100 | |
| $1.34 | -0.03 | -2.2% | $1.42 | $1.49 | $1.32 | 14,700 | |
| $1.37 | -0.03 | -2.1% | $1.50 | $1.50 | $1.35 | 13,700 | |
| $1.40 | -0.05 | -3.4% | $1.50 | $1.648 | $1.38 | 12,100 | |
| $1.45 | -0.17 | -10.5% | $1.62 | $1.64 | $1.38 | 40,600 | |
| $1.62 | -0.03 | -1.8% | $1.66 | $1.76 | $1.55 | 44,200 | |
| $1.65 | -0.088 | -5.1% | $1.77 | $1.78 | $1.61 | 38,700 | |
| $1.738 | -0.112 | -6.1% | $1.80 | $1.86 | $1.72 | 39,700 | |
| $1.85 | -0.02 | -1.1% | $1.81 | $1.90 | $1.78 | 71,000 | |
| $1.87 | -0.12 | -6.0% | $1.92 | $1.94 | $1.81 | 87,600 | |
| $1.99 | -0.12 | -5.7% | $2.13 | $2.13 | $1.93 | 50,800 | |
| $2.11 | +0.08 | +3.9% | $2.02 | $2.18 | $1.83 | 271,500 | |
| $2.03 | -0.37 | -15.4% | $2.33 | $2.33 | $1.83 | 310,500 | |
| $2.40 | +0.20 | +9.1% | $2.53 | $3.34 | $2.16 | 2,895,100 | |
| $2.20 | -0.04 | -1.8% | $2.21 | $2.25 | $2.13 | 19,600 | |
| $2.24 | +0.056 | +2.6% | $2.18 | $2.374 | $2.18 | 30,800 | |
| $2.184 | -0.046 | -2.1% | $2.25 | $2.27 | $2.13 | 19,500 | |
| $2.23 | -0.084 | -3.6% | $2.27 | $2.395 | $2.04 | 94,000 | |
| $2.314 | -0.081 | -3.4% | $2.35 | $2.35 | $2.30 | 5,500 | |
| $2.395 | -0.045 | -1.8% | $2.38 | $2.60 | $2.38 | 13,400 | |
| $2.44 | -0.11 | -4.3% | $2.277 | $2.47 | $2.277 | 20,600 | |
| $2.55 | +0.05 | +2.0% | $2.52 | $2.60 | $2.50 | 14,300 | |
| $2.50 | +0.19 | +8.2% | $2.38 | $2.65 | $2.285 | 51,000 | |
| $2.31 | -0.23 | -9.1% | $2.48 | $2.54 | $2.145 | 70,800 | |
| $2.54 | +0.01 | +0.4% | $2.50 | $2.58 | $2.49 | 14,600 | |
| $2.53 | +0.04 | +1.6% | $2.53 | $2.60 | $2.50 | 16,500 | |
| $2.49 | -0.10 | -3.9% | $2.59 | $2.59 | $2.45 | 23,800 | |
| $2.59 | -0.02 | -0.8% | $2.66 | $2.775 | $2.58 | 24,400 | |
| $2.61 | -0.06 | -2.2% | $2.59 | $2.75 | $2.58 | 28,900 | |
| $2.67 | -0.18 | -6.3% | $2.77 | $2.84 | $2.60 | 36,900 | |
| $2.85 | +0.12 | +4.4% | $2.73 | $2.92 | $2.70 | 72,000 | |
| $2.73 | +0.10 | +3.8% | $2.66 | $2.76 | $2.63 | 38,300 | |
| $2.63 | +0.005 | +0.2% | $2.60 | $2.66 | $2.56 | 29,000 | |
| $2.625 | +0.065 | +2.5% | $2.54 | $2.635 | $2.54 | 21,800 | |
| $2.56 | +0.015 | +0.6% | $2.625 | $2.69 | $2.52 | 40,200 | |
| $2.545 | -0.055 | -2.1% | $2.56 | $2.61 | $2.54 | 24,400 | |
| $2.60 | -0.22 | -7.8% | $2.82 | $2.835 | $2.56 | 86,200 | |
| $2.82 | 0.00 | 0.0% | $2.92 | $2.92 | $2.77 | 16,800 | |
| $2.82 | -0.12 | -4.1% | $2.89 | $2.945 | $2.75 | 36,600 | |
| $2.94 | +0.17 | +6.1% | $2.80 | $2.95 | $2.72 | 44,200 | |
| $2.77 | -0.14 | -4.8% | $2.87 | $2.94 | $2.73 | 91,500 | |
| $2.91 | -0.09 | -3.0% | $3.00 | $3.00 | $2.90 | 35,900 | |
| $3.00 | -0.19 | -6.0% | $3.14 | $3.19 | $2.90 | 80,900 | |
| $3.19 | -0.26 | -7.5% | $3.51 | $3.51 | $3.14 | 119,000 | |
| $3.45 | +0.27 | +8.5% | $3.20 | $3.64 | $3.10 | 499,000 | |
| $3.18 | +0.42 | +15.2% | $3.24 | $4.29 | $2.81 | 18,126,600 | |
| $2.76 | -0.05 | -1.8% | $2.78 | $2.82 | $2.76 | 24,100 | |
| $2.81 | -0.05 | -1.7% | $2.81 | $2.835 | $2.80 | 26,600 | |
| $2.86 | +0.04 | +1.4% | $2.849 | $2.89 | $2.78 | 51,300 | |
| $2.82 | +0.04 | +1.4% | $2.76 | $2.89 | $2.71 | 31,400 | |
| $2.78 | -0.09 | -3.1% | $2.89 | $2.89 | $2.76 | 38,300 | |
| $2.87 | -0.01 | -0.3% | $2.83 | $2.91 | $2.83 | 20,500 | |
| $2.88 | -0.10 | -3.4% | $2.99 | $2.99 | $2.79 | 35,700 | |
| $2.98 | +0.21 | +7.6% | $2.81 | $2.981 | $2.71 | 65,200 | |
| $2.77 | -0.14 | -4.8% | $2.76 | $2.907 | $2.74 | 79,600 | |
| $2.91 | -0.07 | -2.3% | $3.10 | $3.10 | $2.84 | 49,000 | |
| $2.98 | +0.04 | +1.4% | $2.84 | $3.07 | $2.84 | 141,000 |
- Ticker
- NASDAQ:VRAX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
Virax Biolabs Appoints Three Distributors for ImmuneSelect Research Products in Mainland China
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 20 slides
Latest news
Virax Biolabs Appoints Three Distributors for ImmuneSelect Research Products in Mainland China
Oct 29, 2026
Closed $1.32 (+10.0%) on Oct 29, 2026
Alliance Entertainment and Virax Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Jul 20, 2026
Closed $3.89 (+2.6%) on Jul 20, 2026
Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement
Jul 16, 2026
Closed $3.90 (+13.0%) on Jul 16, 2026
Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds
Jul 10, 2026
Closed $4.07 (-0.2%) on Jul 13, 2026
Virax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds
Jul 9, 2026
Closed $6.36 (+100.0%) on Jul 9, 2026
Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics
Jul 9, 2026
Closed $6.36 (+100.0%) on Jul 9, 2026
Virax Biolabs Group Limited Announces 1-for-25 Share Consolidation
Jun 24, 2026
Closed $3.30 (-14.8%) on Jun 24, 2026
Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes
May 26, 2026
Closed $5.68 (-18.3%) on May 26, 2026
Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation
Mar 31, 2026
Closed $5.50 (+35.0%) on Mar 31, 2026
Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement
Dec 4, 2025
Closed $15.75 (-2.2%) on Dec 5, 2025
Financings
Ordinary shares on exercise of preferred investment options
Jul 16, 2026
Closed: US$3.3M in the latest tranche · US$6 a share · Warrants at US$6 · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital for general corporate purposes
Announced Jul 9, 2026 · Closed Jul 10, 2026 · Closed Jul 16, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 20 slides · September 2026
Investor Presentation (April 2026)
Investor deck · 16 slides · April 2026
IPO Roadshow (July 2022)
IPO roadshow · 23 slides · Jul 1, 2022
Virax Biolabs Group Limited on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 12 in the last 12 months · 46 in all · newest Oct 29, 2026 · oldest 2022
- Decks
- 3 decks · latest September 2026
Where Virax Biolabs Group Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VRAX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:VRAX | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Virax Biolabs Group Limited.